Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

R&D Systems™ Recombinant Human Kininostatin Protein

Catalog No. 1396KN050
Click to view available options
Formulation:
Lyophilized from a 0.2μm filtered solution in PBS with BSA as a carrier protein.
Lyophilized from a 0.2μm filtered solution in PBS.
This item is not returnable. View return policy
This item is not returnable. View return policy

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

Measured by its ability to induce apoptosis of HUVEC human umbilical vein endothelial cells. Colman, R.W. et al. (2001) Arterioscler. Thromb. Vasc. Biol. 21:1427. The ED50 for this effect is 1-7 μg/mL in the presence of 10 ng/mL of rhFGF basic.

Specifications

Formulation Lyophilized from a 0.2μm filtered solution in PBS with BSA as a carrier protein.
Gene ID (Entrez) 3827
Molecular Weight (g/mol) 10.5 kDa
Name Kininostatin
Quantity 50 μg
Source E. coli-derived human Kininostatin protein Lys438-Ser531
Storage Requirements Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
Conjugate Unconjugated
Recombinant Recombinant
Purity or Quality Grade >95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.